atorvastatin has been researched along with Vascular Injuries in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botelho, T; de Batista, PR; Padilha, AS; Ribeiro-Júnior, RF; Simões, FV; Vassallo, DV | 1 |
| Dong, J; Liao, L; Liu, F; Liu, J; Mou, Y; Shen, X; Yang, T; Zhou, X | 1 |
| Fagan, SC; Guan, W; Kozak, A | 1 |
| Breborowicz, A; Kawka, E; Korybalska, K; Witowski, J | 1 |
4 other study(ies) available for atorvastatin and Vascular Injuries
| Article | Year |
|---|---|
Treatment with high dose of atorvastatin reduces vascular injury in diabetic rats.
Topics: Animals; Aorta; Atorvastatin; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Endothelium, Vascular; Indomethacin; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitrobenzenes; Phenylephrine; Prostaglandins; Rats; Rats, Wistar; Streptozocin; Sulfonamides; Superoxides; Vascular System Injuries; Vasodilation; Vasodilator Agents | 2016 |
The role of atorvastatin on the restenosis process post-PTA in a diabetic rabbit model.
Topics: Angioplasty, Balloon; Animals; Atherosclerosis; Atorvastatin; Cell Movement; Cell Proliferation; Constriction, Pathologic; Diabetes Mellitus, Experimental; Disease Models, Animal; Iliac Artery; Male; Myocytes, Smooth Muscle; Neointima; Rabbits; Recurrence; Time Factors; Vascular Patency; Vascular System Injuries | 2016 |
Drug repurposing for vascular protection after acute ischemic stroke.
Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Benzimidazoles; Biphenyl Compounds; Brain Infarction; Diabetes Mellitus, Type 2; Disease Models, Animal; Enalapril; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Hemoglobins; Hemorrhage; Heptanoic Acids; Male; Matrix Metalloproteinase 9; Pyrroles; Rats; Rats, Inbred SHR; Rats, Wistar; Reperfusion; Stroke; Tetrazoles; Vascular System Injuries | 2011 |
Atorvastatin does not impair endothelial cell wound healing in an in vitro model of vascular injury.
Topics: Atorvastatin; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Cytokines; Fibronectins; Heptanoic Acids; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; Percutaneous Coronary Intervention; Pyrroles; Vascular System Injuries; Wound Healing | 2012 |